Cleared Traditional

K121223 - QLAB WITH FHN AND VPQ PLUG-IN

K121223 is an FDA 510(k) clearance for QLAB WITH FHN AND VPQ PLUG-IN, manufactured by Philips Ultrasound, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 22-day FDA review.

K121223 · Philips Ultrasound, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2012
Decision
22d
Days
Class 2
Risk

K121223 is an FDA 510(k) clearance for the QLAB WITH FHN AND VPQ PLUG-IN. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Ultrasound, Inc. (Andover, US). The FDA issued a Cleared decision on May 15, 2012 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Philips Ultrasound, Inc. devices

FDA 510(k) Submission Details - K121223

510(k) Number K121223 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2012
Decision Date May 15, 2012
Days to Decision 22 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 107d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1192
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K121223.
SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS
K120648 · Fujifilm Medical System U.S.A., Inc. · Jun 2012
SCENIUM 2.0
K121074 · Siemens Medical Solutions USA, Inc. · Jun 2012
SYNAPSE 3D NODULE ANALYSIS
K120679 · Fujifilm Medical Systems U.S.A, Inc. · Jun 2012
SYNAPSE 3D BRAIN PERFUSION
K120637 · Fujifilm Medical System U.S.A., Inc. · May 2012
SURGICASE CONNECT
K113599 · Materialise NV · Apr 2012
3.7 MP COLOR LCD MONITOR, RADIFORCE MX270W
K113240 · Eizo Nanao Corporation · Apr 2012